Modulate Bio

📍 Cambridge, United States🗓 Founded 2023👥 5 employees💰 Last funded Oct 2024
Biotechnology Research🌐 modulatebio.com
Website LinkedIn
Modulate Bio is developing next-gen GABA-A positive allosteric modulators to treat neurological disorders, including Essential Tremor, epilepsy and anxiety, without the sedative effects associated with benzodiazepines and neurosteroids.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Italy
1
Frequently asked questions
Who invested in Modulate Bio?
Modulate Bio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Modulate Bio last raise funding?
The most recent investment in Modulate Bio recorded on gritt.io was in October 2024.
When was Modulate Bio founded?
Modulate Bio was founded in 2023.
What industry is Modulate Bio in?
Modulate Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Modulate Bio based?
Modulate Bio is headquartered in Cambridge, United States.